PTC Therapeutics will be hosting an Informational Patient Webinar on July 28th at 7pm for those interested in learning more about PTC-743, a candidate molecule for the treatment of Friedreich's ataxia. The clinical trial for PTC-743 will be international and include clinic sites in Australia, Brazil, Canada, the E.U., and the U.S.
Please email info@curefa.org if you are interested in attending this Webinar.
SHARE
